The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects
Clinical trial NCT00146289 · COMPLETED
Trial details
- NCT number
- NCT00146289
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2005-10-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.